Insider buying
~$91K1,500 sh @ $60.53
First insider buy since May 2024Traded Nov 17 · filed 1 day later
The CEO of National Health Investors paid $91K out of pocket for National Health Investors shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NHI · NYSE · Health Care REITs
National Health Investors, Inc. (NHI) · oqro.io/stocks/NHI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$59.98−0.79 (−1.30%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Insider buying
First insider buy since May 2024Traded Nov 17 · filed 1 day later
The CEO of National Health Investors paid $91K out of pocket for National Health Investors shares.
1 open-market purchase and 0 open-market sales by insiders of NHI between Jan 27, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 9, 2026. The data provider lists the next release for Feb 24, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 9, 2026 | None | None | 1 purchase |
| Aug 10, 2026 | None | None | None |
| May 4, 2026 | None | None | None |
| Feb 26, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies